Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.
Abstract
BACKGROUND
During the past half-century, the ECG has been used extensively for the diagnosis of left ventricular hypertrophy. Persons with ECG evidence of left ventricular hypertrophy are at increased risk for the development of cardiovascular disease.
METHODS AND RESULTS
Subjects from the Framingham Heart Study with ECG evidence of left ventricular hypertrophy were eligible for this investigation if they were free of cardiovascular disease and did not have complete bundle-branch block or Wolff-Parkinson-White syndrome. Logistic regression analyses of pooled biennial examinations were used to determine risk for cardiovascular disease as a function of baseline voltage (sum of R wave in aVL plus S wave in V3) and repolarization and as a function of serial changes in these ECG features of hypertrophy. The eligible sample consisted of 274 men (mean age, 60 years) and 250 women (mean age, 64 years) who contributed 2660 person-examinations. During follow-up, there were 269 new cardiovascular events. Compared with subjects in the first quartile of voltage at baseline, the age-adjusted odds ratio for cardiovascular disease among subjects in the fourth quartile was 3.08 (95% confidence interval [CI], 1.87 to 5.07) in men and 3.29 (95% CI, 1.78 to 6.09) in women. Compared with a normal repolarization pattern, the presence of severe repolarization abnormalities was associated with an age-adjusted odds ratio of 5.84 (95% CI, 3.55 to 9.62) in men and 2.47 (95% CI, 1.38 to 4.42) in women. Subjects with a serial decline in voltage were at lower risk for cardiovascular disease than were those with no serial change (men: odds ratio after adjusting for age and baseline voltage, 0.46; 95% CI, 0.26 to 0.84; women: odds ratio, 0.56; 95% CI, 0.30 to 1.04). In contrast, those with a serial increase in voltage were at greater risk for cardiovascular disease (men: odds ratio, 1.86; 95% CI, 1.14 to 3.03; women: odds ratio, 1.61; 95% CI, 0.91 to 2.84). Compared with those with no serial change, an improvement in repolarization was associated with a marginally significant reduction in cardiovascular risk in men (odds ratio after adjusting for age and baseline repolarization, 0.45; 95% CI, 0.20 to 1.01). Worsening of repolarization was associated with increased risk for cardiovascular disease in both sexes (men: odds ratio, 1.89; 95% CI, 1.05 to 3.40; women: odds ratio, 2.02; 95% CI, 1.07 to 3.81).
CONCLUSIONS
The results of this investigation suggest that regression of ECG features of left ventricular hypertrophy confers an improvement in risk for cardiovascular disease, whereas serial worsening imposes increased risk. The benefits to be derived from regression of left ventricular hypertrophy must be confirmed in other clinical settings.
Formats available
You can view the full content in the following formats:
Information & Authors
Information
Published In
Copyright
Copyright © 1994 by American Heart Association.
History
Published online: 1 October 1994
Published in print: October 1994
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Association between left ventricular hypertrophy and the peak times of the R and P waves in hypertensive patients, Cukurova Medical Journal, 49, 3, (665-672), (2024).https://doi.org/10.17826/cumj.1472267
- Electrocardiographic tracking of left ventricular hypertrophy in hypertension: incidence and prognostic outcomes from the SPRINT trial, Clinical Hypertension, 30, 1, (2024).https://doi.org/10.1186/s40885-024-00275-8
- Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy, Annals of Medicine, 56, 1, (2024).https://doi.org/10.1080/07853890.2024.2405080
- Diagnostic accuracy of artificial intelligence in detecting left ventricular hypertrophy by electrocardiograph: a systematic review and meta-analysis, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-66247-y
- Assessment of Hypertension-Mediated Organ Damage, Hypertension, (229-242), (2024).https://doi.org/10.1016/B978-0-323-88369-6.00019-0
- Safety and Efficacy of Anti-Hypertensive Medications in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis, High Blood Pressure & Cardiovascular Prevention, 31, 3, (239-249), (2024).https://doi.org/10.1007/s40292-024-00646-0
- Influence of Dietary Sodium Modulation on Electrocardiographic Voltage Criteria for Left Ventricular Hypertrophy in Normotensive Individuals, Journal of Investigative Medicine, 60, 1, (39-43), (2023).https://doi.org/10.2310/JIM.0b013e31823d05ab
- Exploring the Relationship Between Intensive Blood Pressure Lowering, Left Ventricular Hypertrophy, and Cardiovascular Outcomes, Hypertension, 80, 9, (1843-1844), (2023)./doi/10.1161/HYPERTENSIONAHA.123.21512
- Intensive Blood Pressure Lowering Improves Left Ventricular Hypertrophy in Older Patients with Hypertension: The STEP Trial, Hypertension, 80, 9, (1834-1842), (2023)./doi/10.1161/HYPERTENSIONAHA.122.20732
- Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: A Prospective Cohort Study, Hypertension, 80, 6, (1321-1330), (2023)./doi/10.1161/HYPERTENSIONAHA.122.19988
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.